2023
DOI: 10.1101/2023.09.11.23295362
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Reduced expression of fMRI subsequent memory effects with increasing severity across the Alzheimer’s disease risk spectrum

Joram Soch,
Anni Richter,
Jasmin M. Kizilirmak
et al.

Abstract: In functional magnetic resonance imaging (fMRI) studies, episodic memory is commonly investigated with the subsequent memory paradigm in which brain activity is recorded during encoding and analyzed as a function of subsequent remembering and forgetting. Impaired episodic memory is common in individuals with or at risk for Alzheimer’s disease (AD), but only few studies have reported subsequent memory effects in AD or its risk states like mild cognitive impairment (MCI). One reason for this might be that subseq… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
2

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(7 citation statements)
references
References 78 publications
0
5
2
Order By: Relevance
“…Unlike previous studies of neuropsychological performance in healthy relatives of patients with AD (for a review, see 67 ), we additionally found no performance difference between healthy relatives and control participants (see Fig. 1 in 38 ). However, unlike HC and similar to individuals with SCD, healthy relatives exhibited a significant effect of amyloid positivity on the novelty-SAME score (Figure 5).…”
Section: Single-value Scores Amyloid Status and Genetic Riskcontrasting
confidence: 94%
See 4 more Smart Citations
“…Unlike previous studies of neuropsychological performance in healthy relatives of patients with AD (for a review, see 67 ), we additionally found no performance difference between healthy relatives and control participants (see Fig. 1 in 38 ). However, unlike HC and similar to individuals with SCD, healthy relatives exhibited a significant effect of amyloid positivity on the novelty-SAME score (Figure 5).…”
Section: Single-value Scores Amyloid Status and Genetic Riskcontrasting
confidence: 94%
“…To control for potential confounding variables, we computed a three-way between-subjects ANOVA to assess effects of (i) acquisition site (8 sites; cf. Table 1 in 38 ), (ii) gender (male vs. female), and (iii) diagnostic group (HC, SCD, MCI, AD, AD-rel). Because the factor site had eight levels, we did not include interactions with site in this model.…”
Section: No Associations Of Fade and Same Scores With Site And Gendermentioning
confidence: 99%
See 3 more Smart Citations